Piedmont Investment Advisors’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-10,195
Closed -$824K 1160
2019
Q1
$824K Buy
10,195
+781
+8% +$58.5K 0.03% 341
2018
Q4
$577K Buy
9,414
+378
+4% +$25.6K 0.03% 409
2018
Q3
$650K Sell
9,036
-14
-0.2% -$882 0.03% 417
2018
Q2
$475K Buy
9,050
+761
+9% +$35.8K 0.02% 455
2018
Q1
$360K Buy
8,289
+492
+6% +$22.6K 0.01% 506
2017
Q4
$378K Sell
7,797
-362
-4% -$18.3K 0.01% 490
2017
Q3
$417K Buy
8,159
+123
+2% +$5.89K 0.01% 477
2017
Q2
$346K Buy
+8,036
New +$334K 0.01% 510

Other funds holding OMCL

Piedmont Investment Advisors's OMCL Position: Q2 2019 in Review

Piedmont Investment Advisors sold out of Omnicell (OMCL) in Q2 2019, closing a stake of 10,195 shares — an estimated $824K sold.

Piedmont Investment Advisors first reported a position in OMCL in Q2 2017 and held it in 8 quarters. The position peaked at $824K in Q1 2019. 299 funds tracked by Wall St. Rank hold OMCL as of Q2 2019.

  • Piedmont Investment Advisors reported no remaining Omnicell position as of Q2 2019 after selling out during the quarter.
  • Piedmont Investment Advisors sold 10,195 Omnicell shares in Q2 2019, an estimated $824K.
  • Piedmont Investment Advisors first reported a position in Omnicell in Q2 2017 and held it in 8 quarters.
  • Piedmont Investment Advisors's Omnicell position peaked at $824K in Q1 2019.
  • 299 funds tracked by Wall St. Rank held Omnicell as of Q2 2019.

Based on Piedmont Investment Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.